Abstract
Purpose: Numerous antiemetics have been studied for the prevention of postoperative nausea and vomiting (PONV) including traditional agents (metodopramide, perphenazine, prochlorperazine, cyclizine and droperidol) and the 5-HT3 receptor antagonists (ondansetron, dolasetron, granisetron and tropisetron). The results have been divergent and inconsistent. The purpose of this quantitative systematic review was to evaluate the effectiveness of 5HT3 receptor antagonists compared to traditional antiemetics for the prevention of PONV.
Methods: A systematic search of the English language literature using computerized MEDLINE, EMBASE, and Pre-MEDLINE databases from 1966 to October 1999 and a manual search of references from retrieved articles were performed. Individual efficacy and adverse effect data was extracted from each of the studies according to a predefined protocol. The summary odds ratios were calculated using the Dersimonian and Laird method under a random effects model.
Results: A total of 41 trials met our pre-defined inclusion criteria and were included in our analysis. Results in the 32 studies examining PONV indicated a 46% reduction in the odds of PONV in the 5-HT3-treated group (0.54 [95% Cl 0.42–0.71],P<0.001). evaluation of PONV by traditional antiemetic agent demonstrated a 39% reduction compared with droperidol (0.61 [95% Cl 0.42–0.89],P<0.001) and a 56% reduction compared with metodopramide (0.44 [95% Cl 0.31–0.62],P<0.001). Results in the 34 studies examining vomiting indicated a 38% reduction in the odds of vomiting in the 5-HT3-treated group (0.62 [95% Cl 0.48–0.81],P<0.001).
Conclusions: The 5-HT3 receptor antagonists are superior to traditional antiemetic agents for the prevention of PONV and vomiting. The reduction in the odds of PONV and vomiting is significant in the overall analysis and the subgroup analyses comparing 5-HT3 receptor antagonists with droperidol and metoclopramide.
Résumé
Objectif: La recherche de moyens de prévention des nausées et vomissement postopératoires (NVPO) a porté sur de nombreux antiémétiques induant des médicaments traditionnels (métoclopramide, perphénazine, prochlorpérazine, cyclinzine et dropéridol) et des antagonistes du récepteur 5-HT3 (ondansétron, dolasétron, granisétron et tropisétron). Les résultats ont été divergents et contradictoires. La présente révision systématique quantitative évalue l’efficacité comparée des antagonistes du récepteur 5HT3 et des antiémétiques traditionnels dans la prévention des NVPO.
Méthode: Une recherche systématique des documents de langue anglaise a été faite dans MEDLINE, EMBASE et Pre-MEDLINE, de 1966 à octobre 1999, suivie d’une recherche manuelle des articles retenus. Les données sur l’efficacité individuelle et les effets indésirables ont été extraites de chaque étude selon un protocole prédéfini. Les risques relatifs d’ensemble ont été calculés à l’aide de la méthode de Dersimonian et Laird d’après un modèle d’effet aléatoire.
Résultats: Quarante et un essais répondaient à nos critères d’indusion prédéfinis et ont été retenus dans notre analyse. Les résultats de 32 études sur les NVPO ont indiqué une réduction de 46% du risque relatif de NVPO chez les patients traités avec anti-5-HT3 (0,54 [IC de 95%; 0,42–0,71];P<0,001). Comparés aux autres antiémétiques traditionnels, les anti-5-HT3 ont démontré une réduction du risque relatif de 39% comparés au dropéridol (0,61 [IC de 95%; 0,42–0,89];P<0,001) et de 56% comparés au métoclopramide (0,44 [IC de 95%; 0,31–0,62];P<0,001). Les résultats de 34 études sur les vomissements ont indiqué une réduction de 38% du risque relatif chez les patients traités avec anti-5-HT3 (0,62 [IC de 95%; 0,48–0,81];P<0,001).
Conclusion: Les antagonistes du récepteur 5-HT3 ont une action supérieure aux antiémétiques traditionnels pour prévenir les NVPO et les vomissements. La réduction de la probabilité de NVPO et de vomissements est significative dans l’analyse globale et dans les analyses de sous-groupes où on a comparé les antagonistes du récepteur 5-HT3 avec le dropériodol et le métodopramide.
Article PDF
Similar content being viewed by others
References
Wetchler BV. Postoperative nausea and vomiting in day-case surgery. Br J Anaesth 1992; 69: 338–9.
Haigh CG, Kaplan LA, Durham JM, Dupeyron JP, Harmer M, Kenny GNC. Nausea and vomiting after gynaecological surgery: a meta-analysis of factors affecting their incidence. Br J Anaesth 1993; 71: 517–22.
Madej TH, Simpson KH. Comparison of the use of domperidone, droperidol, and metoclopramide in the prevention of nausea and vomiting following major gynaecological surgery. Br J Anaesth 1986; 58: 884–7.
Sanchez LA, Hirsch JD, Carroll NV, Miederhoff PA. Estimation of the cost of postoperative nausea and vomiting in an ambulatory surgery center. J Res Pharm Econ 1995; 6: 35–44.
Graczyk SG, McKenzie R, Kallar S, et al. Intravenous dolasetron for the prevention of postoperative nausea and vomiting after outpatient laparoscopic surgery. Anesth Analg 1997; 84: 325–30.
Helmers JH, Briggs L, Abrahamsson J, et al. A singleiv dose of ondansetron 8 mg prior to induction of anaesthesia reduces postoperative nausea and vomiting in gynaecological patients. Can J Anaesth 1993; 40: 1155–61.
Tang J, Wang B, White PF, Watcha MF, Qi J, Wender RH. The effect of timing of on dansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting. Anesth Analg 1998; 86: 274–82.
Gold BS.Kitz DS, Lecky JH, Neuhaus JM. Unanticipated admission to the hospital following ambuatory surgery. JAMA 1989; 262: 3008–10.
Fancourt-Smith PF, Hornstein J, Jenkins LC. Hospital admissions from the Surgical Daycare Centre of Vancouver General Hospital 1977–1987. Can J Anaesth 1990; 37: 699–704.
Fortier J, Chung F, Su J. Unanticipated admission after ambulatory surgery - a prospective study. Can J Anaesth 1998; 45: 612–9.
Fujii Y, Tanaka H, Toyooka H. Prevention of nausea and vomiting in female patients undergoing breast surgery: a comparison with granisetron, droperidol, metoclopramide and placebo. Acta Anaesthesiol Scand 1998; 42: 220–4.
Fujii Y, Tanaka H, Toyooka H. Granisetron reduces the incidence and severity of nausea and vomiting after laparoscopic cholecystectomy. Can J Anaesth 1997; 44: 396–400.
Koivuranta M, Läärä E, Ranta P, Ravaska P, Alahuhta S. Comparison of ondansetron and droperidol in the prevention of postoperative nausea and vomiting after laparoscopic surgery in women. Acta Anaesthesiol Scand 1997; 41: 1273–9.
Fortney JT, Gan TJ, Graczyk S, et al. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. Anesth Analg 1998; 86: 731–8.
Kaul HL, Rao U, Mandal NG, Rahman A. Comparative evaluation of single dose oral ondansetron and metoclopramide in a placebo-controlled study for prevention of post-operative nausea and vomiting. J Anaesth Clin Pharmacol 1995; 12: 27–30.
Naguib M, El Bakry AK, Khoahim MHB, et al. Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholystectomy: a randomized, double-blind comparison with placebo. Can J Anaesth 1996; 43: 226–31.
Fujii Y, Toyooka H, Tanaka H. Prevention of Postoperative nausea and vomiting with a combination of granisetron and droperidol. Anesth Analg 1998; 86: 613–6.
Fujii Y, Saitoh Y, Tanaka H, Toyooka H. Prophylactic antiementic therapy with granisetron-droperidol combination in patients undergoing laparoscopic cholecystectomy. Can J Anaesth 1998; 45: 541–4.
Fujii Y, Tanaka H, Toyooka H. Prevention of postoperative nausea and vomiting with granisetron: a randomized, double-blind comparison with droperidol. Can J Anaesth 1995; 42: 852–6.
Fujii Y, Tanaka H, Toyooka H. Reduction of postoperative nausea and vomiting with granisetron. Can J Anaesth 1994; 41: 291–4.
Fujii Y, Tanaka H, Toyooka H. The effects of dexamethasone on antiemetics in female patients undergoing gynecologic surgery. Anesth Analg 1997; 85: 913–7.
Fujii Y, Toyooka H, Tanaka H. Prevention of PONV with granisetron, droperidol and metoclopramide in female patients with history of motion sickness. Can J Anaesth 1997; 44: 820–4.
Fujii Y, Saitoh Y, Tanaka H, Toyooka H. Prevention of PONV with granisetron, droperidol or metoclopramide in patients with postoperative emesis. Can J Anaesth 1998; 45: 153–6.
Fujii Y, Toyooka H, Tanaka H. Prevention of postoperative nausea and vomiting in female patients during menstruation: comparison of droperidol, metoclopramide and granisetron. Br J Anaesth 1998; 80: 248–9.
Grond S, Lynch J, Diefenbach C, Altrock K, Lehmann KA. Comparison of ondansetron and droperidol in the prevention of nausea and vomiting after inpatient minor gynecologic surgery. Anesth Analg 1995; 81: 603–7.
Paech MJ, Pavy TJG, Evans SF. Single-dose prophylaxis for postoperative nausea and vomiting after major abdominal surgery: ondansetron versus droperidol. Anaesth Intensive Care 1995; 23: 548–54.
Paxton LD, McKay AC, Mirakhur RK. Prevention of nausea and vomiting after day case gynaecological laparoscopy. A comparison of ondansetron, droperidol, metoclopramide and placebo. Anaesthesia 1995; 50: 403–6.
Wrench IJ, Ward JEH, Walder AD, Hobbs GJ. The prevention of postoperative nausea and vomiting using a combination of ondansetron and droperidol. Anaesthesia 1996; 51: 776–8.
Pueyo FJ, Carrascosa F, Lopez L, Iribarren MJ, García-Pedrajas F, Saez A. Combination of ondansetron and droperidol in the prophylaxis of postoperative nausea and vomiting. Anesth Analg 1996; 83: 117–22.
Sniadach MS, Alberts MS. A comparison of the prophylactic antiemetic effect of ondansetron and droperidol on patients undergoing gynecologic laparoscopy. Anesth Analg 1997; 85: 797–800.
Tang J, Watcha MF, White PF. A comparison of costs and efficacy of ondansetron and droperidol as prophylactic antiemetic therapy for elective outpatient gynecologic procedures. Anesth Analg 1996; 83: 304–13.
Alon E, Himmelseher S. Ondansetron in the treatment of postoperative vomiting: a randomized, double-blind comparison with droperidol and metoclopramide. Anesth Analg 1992; 75: 561–5.
Desilva PHDP, Darvish AH, McDonald SM, Cronin MK, Clark K. The efficacy of prophylactic ondansetron, droperidol, perhenazine, and metoclopramide in the prevention of nausea and vomiting after major gynecologic surgery. Anesth Analg 1995; 81: 139–43.
Raphael JH, Norton AC. Antiemetic efficacy of prophylactic ondansetron in laporoscopic surgery: randomized, double-blind comparison with metoclopramide. Br J Anaesth 1993; 71: 845–8.
Malins AF, Field JM, Nesling PM, Copper GM. Nausea and vomiting after gynaecologocal laparoscopy: a comparison of premedication with oral ondansetron, metoclopramide and placebo. Br J Anaesth 1994; 72: 231–3.
Chen PP, Chui PT, Gin T. Comparison of ondansetron and metoclopramide for the prevention of post-operative nausea and vomiting after major gynaecologic surgery. Eur J Anaesthesiol 1996; 13: 485–91.
Monagle J, Barnes R, Goodchild C, Hewitt M. Ondansetron is not superior to moderate dose meto-clopramide in the prevention of post-operative nausea and vomiting after minor gynecological surgery. Eur J Anaesthesiol 1997; 14: 604–9.
Morris RW, Aune H, Feiss P, et al. International, muti-centre, placebo-controlled study to evaluate the effectiveness of ondansetron vs. metoclopramide in the prevention of post-operative nausea and vomiting. Eur J Anaesthesiol 1998; 15: 69–79.
Watts SA. A randomized double-blinded comparison of metoclopramide, ondansetron and cyclizine in day-case laproscopy. Aust Soc Anaesth 1996; 24: 546–51.
Purhonen S, Kauko M, Koski EMJ, Nuutinen L. Comparison of tropisetron, droperidol, and saline in the prevention of postoperative nausea and vomiting after gynecologic surgery. Anesth Analg 1997; 84: 662–7.
van der Bery AA. The prophylactic antiemetic efficacy of prochlorperazine and ondansetron in nasal septal surgery: a randomized double-blind comparison. Aust Soc Anaesth 1996; 24: 538–45.
Pugh SC, Jones NC, Barsoum LZ. A comparison of prophylactic ondansetron and metoclopramide adminitration in patients undergoing major neurosurgical procedures. Anaesthesia 1996; 51: 1162–4.
Ali-Melkkilä T, Kanto J, Katevuo R. Tropisetron and metoclopramide in the prevention of postoperative nausea and vomiting. Anaesthesia 1996; 51: 232–5.
Ascaso FJ, Ayala I, Carbonell P, Castro FJ, Palomar A. Prophylactic intravenous ondansetron in patients undergoing cataract extraction under general anesthesia. Ophthalmologica 1997; 211: 292–5.
Gan TJ, Collis GR, Hetreed M. Mouble-blind comparison of ondansetron, droperidol and saline in the prevention of postoperative nausea and vomiting. Br J Anaesth 1994; 72: 544–7.
Alexander R, Lovell AT, Seingry D, Jones RM. Comparison of ondansetron and droperidol in reducing postoperative nausea and vomiting associated with patient-controlled analgesia. Anaesthesia 1995; 50: 1086–8.
Alexander R, Fennelly M. Comparison of ondansetron, metoclopramide and placebo as premedicants to reduce nausea and vomiting after major surgery. Anaesthesia 1997; 52: 695–703.
Chen JJ, Frame DG, White TJ. Efficacy of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting after total hip replacement or total knee replacement procedures. Arch Intern Med 1998; 158: 2124–8.
Jellish WS, Leonetti JP, Fluder E, Thalji Z. Ondansetron versus droperidol or placebo to prevent nausea and vomiting after otologic surgery. Otolaryngol Head Neck Surg 1998; 118: 785–9.
van den Berg AA. A omparison of ondansetron and prochlorperazine for the prevention of nausea and vomiting after tympanoplasty. Can J Anaesth 1996; 43: 939–45.
Yilmazlar A, Yilmazlar T, Gürpinar E, Korun N, Kutlay O. Anti-emetic efficacy of tropisetron and metocloprmiade. J Int Med Res 1996; 24: 266–70.
Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77: 162–84.
Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–88.
Cook DJ, Sackett DL, Spitzer WO. Methodologic guidelines for systematic reviews of randomized controlled trials in health care from the Potsdam consultation on meta-analysis. J Clin Epidemiol 1995; 48: 167–71.
Fleiss JL. Analysis of data from multiclinic trials. Control Clin Trials 1986; 7: 267–75.
Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988; 7: 889–94.
Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994; 309: 1351–5.
Rosenthal R. Meta-analysis: a review. Psychosomatic Medicine 1991; 53: 247–71.
Jellish WS, Thalji Z, Fluter E, Leonetti JP. Ondansetron versus droperidol or placebo when given prophylactically for prevention of postoperative nausea and vomiting in patients undergoing middle ear procedures. J Clin Anesth 1997; 9: 451–6.
Doe EA, Jones P, O’Hara HA. A comparison of prophylactic ondansetron hydrochloride and droperidol for strabismus repair in adults. Pediatr Ophthmal Strabismus 1998; 35: 264–9.
Pitkänen MT, Numminen MK, Tuominen MK, Rosenberg PH. Comparison of metoclopramide and ondansetron for the prevention of nausea and vomiting after intrathecal morphine. Eur J Anaesthesiol 1997; 47: 172–7.
Pan PH, Moore CH. Intraoperative antiemetic efficacy of prophylactic ondansetron versus droperidol for Cesarean section patients under epidural anesthesia. Anesth Analg 1996; 83: 982–6.
Kortilla K. The study of postoperative nausea and vomiting. Br J Anaesth 1992; 69(7 Suppl 1): 20S-3.
Tramèr MR, Reynolds DJM, Moore RA, McQuay HJ. Efficacy, dose-response and safety on dansetron in prevention of postoperative nausea and vomiting. A quantitative systematic review of randomized placebo-controlled trials. Anesthesiology 1997; 87: 1277–89.
Kortilla K, Clergue F, Leeser J, et al. Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. Acta Anaesthesiol Scand 1997; 41: 914–22.
Stern JM, Simes RJ. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ 1997; 315: 640–5.
Tramère MR, Reynolds DJM, Moore RA, McQuay HJ. Impact of covert duplicate publication on meta-analysis: a case study. BMJ 1997; 315: 635–40.
Domino KB, Anderson EA, Polissar NL, Posner KL. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis. Anesth Analg 1999; 88: 1370–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Loewen, P.S., Marra, C.A. & Zed, P.J. 5-HT3 receptor antagonistsvs traditional agents for the prophylaxis of postoperative nausea and vomiting. Can J Anesth 47, 1008–1018 (2000). https://doi.org/10.1007/BF03024875
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03024875